Xenoport, Inc. (XNPT) Soars: Stock Up 5.9% - Tale of the Tape

by Zacks, Benzinga Contributor
May 29, 2014 10:11 AM | 1 min read |
Xenoport, Inc. XNPT was a big mover last session, as its shares rose nearly 6% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This continues the trend for the company since May 9, as the stock now up over 30%.

In the last 30 days, the company witnessed two negative estimate revisions and the Zacks Consensus Estimate also moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday's move higher lasts.

Xenoport currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the medical sector include Gilead Sciences Inc. GILD, ANI Pharmaceuticals, Inc. ANIP and Illumina Inc. ILMN. All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
ANI PHARMACEUT ANIP: Free Stock Analysis Report
 
GILEAD SCIENCES GILD: Free Stock Analysis Report
 
ILLUMINA INC ILMN: Free Stock Analysis Report
 
XENOPORT INC XNPT: Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!